Eventide Asset Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $22.8M | Sell |
|
|||||
|
2023
Q3 | $53.9M | Buy |
|
|||||
|
2023
Q2 | $51.4M | Sell |
|
|||||
|
2023
Q1 | $83.9M | Buy |
|
|||||
|
2022
Q4 | $95.6M | Sell |
|
|||||
|
2022
Q3 | $124M | Hold |
|
|||||
|
2022
Q2 | $111M | Sell |
|
|||||
|
2022
Q1 | $156M | Sell |
|
|||||
|
2021
Q4 | $235M | Hold |
|
|||||
|
2021
Q3 | $279M | Buy |
|
|||||
|
2021
Q2 | $223M | Hold |
|
|||||
|
2021
Q1 | $219M | Sell |
|
|||||
|
2020
Q4 | $284M | Sell |
|
|||||
|
2020
Q3 | $264M | Hold |
|
|||||
|
2020
Q2 | $253M | Buy |
|
|||||
|
2020
Q1 | $191M | Hold |
|
|||||
|
2019
Q4 | $236M | Hold |
|
|||||
|
2019
Q3 | $164M | Hold |
|
|||||
|
2019
Q2 | $196M | Hold |
|
|||||
|
2019
Q1 | $200M | Hold |
|
|||||
|
2018
Q4 | $106M | Buy |
|
|||||
|
2018
Q3 | $109M | Buy |
|
|||||
|
2018
Q2 | $92.3M | Buy |
|
|||||
|
2018
Q1 | $87.1M | Hold |
|
|||||
|
2017
Q4 | $53.4M | Buy |
|
|||||
|
2017
Q3 | $43.7M | Buy |
|
|||||
|
2017
Q2 | $17.8M | Buy |
|
|||||
|
2017
Q1 | $6.89M | Buy |
|
|||||
|
2016
Q4 | $4.63M | Buy |
|